Indole-3-Carbinol
I3C
Snapshot
| Indications | Contraindications |
|---|---|
Indole-3-carbinol (I3C) is the breakdown product of glucosinolates in cruciferous vegetables such as broccoli, cabbage, and Brussels sprouts4. It shifts estrogen metabolism toward the 2-hydroxylated pathway1, 3. Supplementation is used for breast cancer risk reduction in women at increased risk, and for precancerous cervical and vulvar lesions4. It is also used in recurrent respiratory papillomatosis and for prostate health.
Human data rest largely on biomarker endpoints.2, 3 Urinary estrogen metabolite ratios rose with indole-3-carbinol in women at increased breast cancer risk in two small trials lasting four to eight weeks; neither tested whether the rise was sustained longer2, 3. Memorial Sloan Kettering states that I3C has cancer-preventive effects but has not been shown to treat cancer in humans, and some animal studies suggest tumor promotion4. An uncontrolled phase I trial in recurrent respiratory papillomatosis found papilloma growth stopped in some patients5. A 2026 systematic review of a combined I3C and epigallocatechin-3-gallate supplement in men reported lower benign prostatic hyperplasia symptom severity6. There are 332 products listing I3C, sampled as capsules; see Form comparison.
The main interaction concern is enzyme induction: I3C raised cytochrome P450 1A2 (CYP1A2) activity in nearly all women in a phase I trial3. Memorial Sloan Kettering's patient page lists use with CYP1A2 substrate medications under "Do Not Take if", while noting clinical relevance has yet to be determined4.
Last updated October 17, 2026. Read how we make monographs.
In the full monograph
27 sources, 15 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Long-term responses of women to indole-3-carbinol or a high fiber diet.pubmed.ncbi.nlm.nih.govBradlow, Michnovicz, Halper et al. · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 1994 · Pubmed
- 2Dose-ranging study of indole-3-carbinol for breast cancer prevention.pubmed.ncbi.nlm.nih.govWong, Bradlow, Sepkovic et al. · Journal of cellular biochemistry. Supplement · 1997 · Pubmed
- 3A phase I study of indole-3-carbinol in women: tolerability and effects.pubmed.ncbi.nlm.nih.govReed, Peterson, Smith et al. · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2005 · Pubmed
- 4MSKCCmskcc.orgMemorial Sloan Kettering — About Herbs, Botanicals & Other Products
- 5Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis.pubmed.ncbi.nlm.nih.govRosen, Woodson, Thompson et al. · Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 1998 · Pubmed
- 6[The role of indole-3-carbinol and epigallocatechin-3-gallate in maintaining men's health (a systematic literature review)].pubmed.ncbi.nlm.nih.govSokolov, Tsareva · Voprosy pitaniia · 2026 · Pubmed
- 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm